Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN954737 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Serotonin Receptor 3E (HTR3E) (AA 133-162), (Middle Region) antibody
- Antibody type
- Polyclonal
- Description
- Affinity chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 133-162, Middle Region
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Two naturally occurring variants of the serotonin receptor gene HTR3C are associated with nausea in pregnancy.
A coding variant of the novel serotonin receptor subunit 5-HT3E influences sustained attention in schizophrenia patients.
Polymorphism in HTR3D shows different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy.
RIC-3 exclusively enhances the surface expression of human homomeric 5-hydroxytryptamine type 3A (5-HT3A) receptors despite direct interactions with 5-HT3A, -C, -D, and -E subunits.
Goecke TW, Ekici AB, Niesler B, Loehberg CR, Hammer C, Rappold G, Schanze D, Straub V, Altmann HH, Strissel P, Strick R, Beckmann MW, Fasching PA
Acta obstetricia et gynecologica Scandinavica 2010;89(1):7-14
Acta obstetricia et gynecologica Scandinavica 2010;89(1):7-14
A coding variant of the novel serotonin receptor subunit 5-HT3E influences sustained attention in schizophrenia patients.
Lennertz L, Wagner M, Frommann I, Schulze-Rauschenbach S, Schuhmacher A, Kühn KU, Pukrop R, Klosterkötter J, Wölwer W, Gaebel W, Rietschel M, Häfner H, Maier W, Mössner R
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2010 Jun;20(6):414-20
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2010 Jun;20(6):414-20
Polymorphism in HTR3D shows different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy.
Hammer C, Fasching PA, Loehberg CR, Rauh C, Ekici AB, Jud SM, Bani MR, Beckmann MW, Strick R, Niesler B
Pharmacogenomics 2010 Jul;11(7):943-50
Pharmacogenomics 2010 Jul;11(7):943-50
RIC-3 exclusively enhances the surface expression of human homomeric 5-hydroxytryptamine type 3A (5-HT3A) receptors despite direct interactions with 5-HT3A, -C, -D, and -E subunits.
Walstab J, Hammer C, Lasitschka F, Möller D, Connolly CN, Rappold G, Brüss M, Bönisch H, Niesler B
The Journal of biological chemistry 2010 Aug 27;285(35):26956-65
The Journal of biological chemistry 2010 Aug 27;285(35):26956-65
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS
